515 related articles for article (PubMed ID: 17537911)
1. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers.
Mani SA; Yang J; Brooks M; Schwaninger G; Zhou A; Miura N; Kutok JL; Hartwell K; Richardson AL; Weinberg RA
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10069-74. PubMed ID: 17537911
[TBL] [Abstract][Full Text] [Related]
2. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.
Taube JH; Herschkowitz JI; Komurov K; Zhou AY; Gupta S; Yang J; Hartwell K; Onder TT; Gupta PB; Evans KW; Hollier BG; Ram PT; Lander ES; Rosen JM; Weinberg RA; Mani SA
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15449-54. PubMed ID: 20713713
[TBL] [Abstract][Full Text] [Related]
3. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.
Yang J; Mani SA; Donaher JL; Ramaswamy S; Itzykson RA; Come C; Savagner P; Gitelman I; Richardson A; Weinberg RA
Cell; 2004 Jun; 117(7):927-39. PubMed ID: 15210113
[TBL] [Abstract][Full Text] [Related]
4. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
5. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.
Hollier BG; Tinnirello AA; Werden SJ; Evans KW; Taube JH; Sarkar TR; Sphyris N; Shariati M; Kumar SV; Battula VL; Herschkowitz JI; Guerra R; Chang JT; Miura N; Rosen JM; Mani SA
Cancer Res; 2013 Mar; 73(6):1981-92. PubMed ID: 23378344
[TBL] [Abstract][Full Text] [Related]
6. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.
Werden SJ; Sphyris N; Sarkar TR; Paranjape AN; LaBaff AM; Taube JH; Hollier BG; Ramirez-Peña EQ; Soundararajan R; den Hollander P; Powell E; Echeverria GV; Miura N; Chang JT; Piwnica-Worms H; Rosen JM; Mani SA
Oncogene; 2016 Nov; 35(46):5977-5988. PubMed ID: 27292262
[TBL] [Abstract][Full Text] [Related]
8. LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis.
Ji X; Lu H; Zhou Q; Luo K
Elife; 2014 Jul; 3():e02907. PubMed ID: 25053741
[TBL] [Abstract][Full Text] [Related]
9. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection.
Jiang W; Pang XG; Wang Q; Shen YX; Chen XK; Xi JJ
Clin Lung Cancer; 2012 Jul; 13(4):280-7. PubMed ID: 22178381
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.
Cho KH; Yu SL; Cho DY; Park CG; Lee HY
BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Forkhead Box c2 with subtypes and invasive ability of invasive breast cancer.
Dai J; Wang JY; Yang LL; Xiao Y; Qu ZL; Qin SH; Ruan QR
J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):896-901. PubMed ID: 25480587
[TBL] [Abstract][Full Text] [Related]
14. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
[TBL] [Abstract][Full Text] [Related]
15. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.
Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G
Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype.
Li Y; Yang W; Yang Q; Zhou S
Histol Histopathol; 2012 Apr; 27(4):475-84. PubMed ID: 22374725
[TBL] [Abstract][Full Text] [Related]
17. Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.
Pillai SG; Li S; Siddappa CM; Ellis MJ; Watson MA; Aft R
Breast Cancer Res; 2018 Jan; 20(1):2. PubMed ID: 29291741
[TBL] [Abstract][Full Text] [Related]
18. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
19. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
20. Overexpressed FOXC2 in ovarian cancer enhances the epithelial-to-mesenchymal transition and invasion of ovarian cancer cells.
Liu B; Han SM; Tang XY; Han L; Li CZ
Oncol Rep; 2014 Jun; 31(6):2545-54. PubMed ID: 24700112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]